3189companies in the directory 652ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform3189companies in the directory 652ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform
DE · EN Newsletter
Biotech & Pharma Symbolbild · KI-generiert
Biotech & Pharma TMED.X

EGF Theramed Health Corp.

TMED.X CSE Biotech & Pharma

Stock factsheet

TickerTMED.X
ExchangeCSE
ISIN
WKN
SectorBiotech & Pharma
Size class Nano Cap
Market capitalisation 523.518 USD As of 2026-08-04

Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.

Company profile

EGF Theramed is a consumer technology company engaged in the provision of biomedical on-line services for monitoring and treating common health problems. The company, through its subsidiaries, has assets and technologies used in the extraction and purification of botanical extracts and the creation of extract formulations, as well as medical monitoring device technology. The company is working to collaborate with other companies for medical technology, equipment protocols and laboratory standard operating procedures.

Company description as published by the issuer via Canadian Securities Exchange.

Comparable companies

Companies in the Biotech & Pharma sector of a similar size.

CompanyTickerExchangeMarket cap
EGF Theramed Health Corp.TMED.X CSE523.518 USD
Element Lifestyle Retirement Inc. ELMTSXV 502.419 USD
Vaxil Bio Ltd. VXLTSXV 497.016 USD
Imaging Dynamics Company Ltd. IDLTSXV 552.540 USD
Waverley Pharma Inc. WAVETSXV 577.425 USD
Entheon Biomedical Corp. ENBI.XCSE 592.777 USD
Jolt Health Inc. JOLT.XCSE 417.390 USD

Investor Relations

Annual reports Not recorded yet
Investor presentation Not recorded yet
Analyst coverage Not recorded yet

We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.

Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.